Health
Association of SLC11A1 polymorphisms with anthropometric and biochemical parameters describing Type 2 Diabetes Mellitus
Cole, J. B. & Florez, J. C. Genetics of diabetes mellitus and diabetes complications. Nat. Rev. Nephrol. 16, 377–390 (2020).
International Diabetes Federation. IDF Diabetes Atlas 9th edn. (International Diabetes Federation, 2023).
Hu, F. B. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 34, 1249–1257 (2011).
Schumann, T. et al. Solute carrier transporters as potential targets for the treatment of metabolic disease. Pharmacol. Rev. 72, 343–379. https://doi.org/10.1124/pr.118.015735 (2020).
Tinajero, M. G. & Malik, V. S. An update on the epidemiology of Type 2 Diabetes: A global perspective. Endocrinol. Metab. Clin. N. Am. 50, 337–355. https://doi.org/10.1016/j.ecl.2021.05.013 (2021).
Malik, V. S., Willet, W. C. & Hu, F. B. Nearly a decade on: Trends, risk factors and policy implications in global obesity. Nat. Rev. Endocrinol. 16, 615–616 (2020).
Trajanoska, K. et al. Assessment of the genetic and clinical determinants of fracture risk: Genome wide association and mendelian randomisation study. BMJ 362, 1–10 (2018).
Morris, A. P. Progress in defining the genetic contribution to type 2 diabetes susceptibility. Curr. Opin. Genet. Dev. 50, 41–51 (2018).
Meigs, J. B. The genetic epidemiology of type 2 diabetes: Opportunities for health translation. Curr. Diab.Rep. 19, 1–8 (2019).
Fuchsberger, C. et al. (2016).
Ahmed, S. A. H., Ansari, S. A., Mensah-Brown, E. P. & Emerald, B. S. The role of DNA methylation in the pathogenesis of Type 2 Diabetes Mellitus. Clin. Epigenet. 12, 1–23 (2020).
Hanson, M. A. & Gluckman, P. D. Early developmental conditioning of later health and disease: Physiology or pathophysiology?. Physiol. Rev. 94, 1027–1076. https://doi.org/10.1152/physrev.00029.2013 (2014).
Zhang, Y., Zhang, Y., Sun, K., Meng, Z. & Chen, L. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development. J. Mol. Cell Biol. 11, 1–13. https://doi.org/10.1093/jmcb/mjy052 (2019).
Chen, E. C. et al. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin. Mol. Pharmacol. 88, 75–83 (2015).
Meyer zu Schwabedissen, H. E., Verstuyft, C., Kroemer, H. K., Becquemont, L. & Kim, R. B. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms. Am. J. Physiol. Renal Physiol. 298, F997–F1005 (2010).
Le, J. et al. Restoration of mRNA expression of solute carrier proteins in liver of diet-induced obese mice by metformin. Front. Endocrinol. 12, 720784–720784. https://doi.org/10.3389/fendo.2021.720784 (2021).
Cellier, M. F. Developmental control of NRAMP1 (SLC11A1) expression in professional phagocytes. Biology 6, 28 (2017).
Yang, J. H. et al. Evidence of association with type 1 diabetes in the SLC11A1 gene region. BMC Med. Genet. 12, 1–11 (2011).
Wessling-Resnick, M. Nramp1 and other transporters involved in metal withholding during infection. J. Biol. Chem. 290, 18984–18990. https://doi.org/10.1074/jbc.R115.643973 (2015).
Forbes, J. R. & Gros, P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102, 1884–1892 (2003).
Mohamed, H. S. et al. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan. Eur. J. Hum. Genet. 12, 66–74 (2004).
Brochado, M. J. F., Gatti, M. F. C., Zago, M. A. & Roselino, A. M. Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample. Mem. Inst. Oswaldo Cruz 111, 101–105 (2016).
Niño-Moreno, P. et al. The role of NRAMP1/SLC11A1 gene variant D543N (1730G/A) in the genetic susceptibility to develop Rheumatoid arthritis in the Mexican Mestizo population. Rev. Invest. Clin. 69, 5–10 (2017).
Sophie, M. et al. SLC11A1 polymorphisms and host susceptibility to cutaneous leishmaniasis in Pakistan. Parasit. Vectors 10, 1–9 (2017).
Ji, J. H. et al. Relationship between heavy metal exposure and type 2 diabetes: A large-scale retrospective cohort study using occupational health examinations. BMJ Open 11, e039541 (2021).
Shidfar, F., Alborzi, F., Salehi, M. & Nojomi, M. Association of waist circumference, body mass index and conicity index with cardiovascular risk factors in postmenopausal women: cardiovascular topic. Cardiovasc. J. Afr. 23, 442–445 (2012).
Mwer, S., Dykes, D. & Polesky, H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
Yong, Y. & He, L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97 (2005).
Piva, F., Giulietti, M., Nocchi, L. & Principato, G. SpliceAid: A database of RNA target motifs bound by splicing proteins in humans. Bioinformatics 25, 1211–1213 (2009).
Crooks, G., Hon, G., Chandonia, J. M. & Brenner, S. E. WebLogo: A sequence logo generator. Genome Res. 14, 1188–1190 (2004).
Schneider, T. D. & Stephens, R. M. Sequence logos: A new way to display consensus sequences. Nucleic Acids Res. 18, 6097–6100 (1990).
Crooks, G. E. WebLogo (Lawrence Berkeley National Lab (LBNL), 2003).
Li, T. et al. A scored human protein–protein interaction network to catalyze genomic interpretation. Nat. Methods 14, 61–64 (2017).
Szklarczyk, D. et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43, D447–D452 (2015).
Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of Type 2 Diabetes Mellitus: Present and future perspectives. Nat. Rev. Endocrinol. 8, 228–236. https://doi.org/10.1038/nrendo.2011.183 (2012).
Xia, Z., Yang, T., Wang, Z., Dong, J. & Liang, C. GRK5 intronic (CA) n polymorphisms associated with type 2 diabetes in Chinese Hainan Island. PLoS ONE 9, e90597 (2014).
Leiria, L. B. et al. The rs225017 polymorphism in the 3′ UTR of the human DIO2 gene is associated with increased insulin resistance. PLoS ONE 9, e103960 (2014).
Virginia, D. M. et al. Single nucleotide polymorphism in the 3’untranslated region of PRKAA2 on cardiometabolic parameters in Type 2 Diabetes Mellitus patients who received metformin. Ther. Clin. Risk Manag. 18, 349 (2022).
Blackwell, J. M. et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 3, 773–784. https://doi.org/10.1046/j.1462-5822.2001.00150.x (2001).
Archer, N. S., Nassif, N. T. & O’Brien, B. A. Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: Systematic review and meta-analysis. Genes Immun. 16, 275–283 (2015).
Donninger, H. et al. Functional analysis of novel SLC11A1 (NRAMP1) promoter variants in susceptibility to HIV-1. J. Med. Genet. 41, e49–e49 (2004).
Ling, Y. et al. A genetic variant in SLC6A20 is associated with Type 2 diabetes in white-European and Chinese populations. Diabet. Med. 31, 1350–1356. https://doi.org/10.1111/dme.12528 (2014).
Xu, J., Wang, J. & Chen, B. SLC30A8 (ZnT8) variations and type 2 diabetes in the Chinese Han population. Genet. Mol. Res. 11, 1592–1598. https://doi.org/10.4238/2012.May.24.1 (2012).
Zaahl, M. G., Winter, T. A., Warnich, L. & Kotze, M. J. The− 237C→ T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population. Int. J. Colorectal Dis. 21, 402–408 (2006).
Zaahl, M. G., Robson, K. J., Warnich, L. & Kotze, M. J. Expression of the SLC11A1 (NRAMP1) 5′-(GT) n repeat: Opposite effect in the presence of− 237C→ T. Blood Cells Mol. Dis. 33, 45–50 (2004).
Kissler, S. et al. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38, 479–483 (2006).
Dai, Y. D. et al. Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens. Diabetes 58, 156–164 (2009).
Yang, J. H. et al. Evidence of association with type 1 diabetes in the SLC11A1 gene region. BMC Med. Genet. 12, 59. https://doi.org/10.1186/1471-2350-12-59 (2011).
Takahashi, K. et al. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese. Tissue Antigens 63, 231–236 (2004).
Paccagnini, D. et al. Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS ONE 4, e7109 (2009).
Aenkoe, M.-L. Seminars in Cell & Developmental Biology 11–21 (Elsevier, 2022).
Liu, Q., Fang, L. & Wu, C. Alternative splicing and isoforms: From mechanisms to diseases. Genes 13, 401 (2022).
Lo, C.-S. et al. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice. Diabetes 61, 2597–2608 (2012).
Ghosh, A. et al. Insulin inhibits Nrf2 gene expression via heterogeneous nuclear ribonucleoprotein F/K in diabetic mice. Endocrinology 158, 903–919 (2017).
Nishida, Y., Aida, K., Kihara, M. & Kobayashi, T. Antibody-validated proteins in inflamed islets of fulminant type 1 diabetes profiled by laser-capture microdissection followed by mass spectrometry. PLoS ONE 9, e107664 (2014).
Tacke, R. & Manley, J. L. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14, 3540–3551 (1995).
He, X. & Zhang, J. Why do hubs tend to be essential in protein networks?. PLoS Genet. 2, e88 (2006).
Ozbayer, C. et al. The genetic variants of solute carrier family 11 member 2 gene and risk of developing type-2 diabetes. J. Genet. 97, 1407–1412 (2018).
Hao, L. et al. SLC40A1 mediates ferroptosis and cognitive dysfunction in type 1 diabetes. Neuroscience 463, 216–226 (2021).
Sudhahar, V. et al. Akt2 (protein kinase B beta) stabilizes ATP7A, a copper transporter for extracellular superoxide dismutase, in vascular smooth muscle: Novel mechanism to limit endothelial dysfunction in Type 2 Diabetes Mellitus. Arterioscler. Thromb. Vasc. Biol. 38, 529–541 (2018).
Lam, K., Ma, O., Wat, N., Chan, L. & Janus, E. β-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with Type II diabetes. Diabetologia 42, 1250–1253 (1999).
Hwang, J.-Y., Ryu, M.-H., Go, M.-J., Oh, B.-S. & Cho, Y.-S. Association between single nucleotide polymorphisms of the fibrinogen alpha chain (FGA) gene and Type 2 Diabetes Mellitus in the Korean population. Genomics Inf. 7, 57–64 (2009).
Li, R. & Guo, K. Mutation of SLC40A1 gene in newly diagnosed type 2 diabetic patients with iron overload. Chin. J. Diabetes 1, 691–696 (2017).
Vojtková, J. et al. An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes. Mol. Biol. Rep. 48, 4397–4404 (2021).
Deng, N., Zhou, H., Fan, H. & Yuan, Y. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8, 110635 (2017).
Nair, V., Sankaranarayanan, R. & Vasavada, A. R. Deciphering the association of intronic single nucleotide polymorphisms of crystallin gene family with congenital cataract. Indian J. Ophthalmol. 69, 2064 (2021).
Mattick, J. S. Introns: Evolution and function. Curr. Opin. Genet. Dev. 4, 823–831 (1994).
Jegga, A. G. & Aronow, B. J. Evolutionarily conserved noncoding DNA. eLS (2008).
Prakasam, P., Abdul Salam, A. A. & Basheer Ahamed, S. I. The pathogenic effect of SNPs on structure and function of human TLR4 using a computational approach. J. Biomol. Struct. Dyn. 1, 1–14 (2023).
Wessel, J. et al. Rare non-coding variation identified by large scale whole genome sequencing reveals unexplained heritability of type 2 diabetes. MedRxiv 2020, 20221812 (2020).
|
Sources 2/ https://www.nature.com/articles/s41598-023-33239-3 The mention sources can contact us to remove/changing this article |
What Are The Main Benefits Of Comparing Car Insurance Quotes Online
LOS ANGELES, CA / ACCESSWIRE / June 24, 2020, / Compare-autoinsurance.Org has launched a new blog post that presents the main benefits of comparing multiple car insurance quotes. For more info and free online quotes, please visit https://compare-autoinsurance.Org/the-advantages-of-comparing-prices-with-car-insurance-quotes-online/ The modern society has numerous technological advantages. One important advantage is the speed at which information is sent and received. With the help of the internet, the shopping habits of many persons have drastically changed. The car insurance industry hasn't remained untouched by these changes. On the internet, drivers can compare insurance prices and find out which sellers have the best offers. View photos The advantages of comparing online car insurance quotes are the following: Online quotes can be obtained from anywhere and at any time. Unlike physical insurance agencies, websites don't have a specific schedule and they are available at any time. Drivers that have busy working schedules, can compare quotes from anywhere and at any time, even at midnight. Multiple choices. Almost all insurance providers, no matter if they are well-known brands or just local insurers, have an online presence. Online quotes will allow policyholders the chance to discover multiple insurance companies and check their prices. Drivers are no longer required to get quotes from just a few known insurance companies. Also, local and regional insurers can provide lower insurance rates for the same services. Accurate insurance estimates. Online quotes can only be accurate if the customers provide accurate and real info about their car models and driving history. Lying about past driving incidents can make the price estimates to be lower, but when dealing with an insurance company lying to them is useless. Usually, insurance companies will do research about a potential customer before granting him coverage. Online quotes can be sorted easily. Although drivers are recommended to not choose a policy just based on its price, drivers can easily sort quotes by insurance price. Using brokerage websites will allow drivers to get quotes from multiple insurers, thus making the comparison faster and easier. For additional info, money-saving tips, and free car insurance quotes, visit https://compare-autoinsurance.Org/ Compare-autoinsurance.Org is an online provider of life, home, health, and auto insurance quotes. This website is unique because it does not simply stick to one kind of insurance provider, but brings the clients the best deals from many different online insurance carriers. In this way, clients have access to offers from multiple carriers all in one place: this website. On this site, customers have access to quotes for insurance plans from various agencies, such as local or nationwide agencies, brand names insurance companies, etc. "Online quotes can easily help drivers obtain better car insurance deals. All they have to do is to complete an online form with accurate and real info, then compare prices", said Russell Rabichev, Marketing Director of Internet Marketing Company. CONTACT: Company Name: Internet Marketing CompanyPerson for contact Name: Gurgu CPhone Number: (818) 359-3898Email: [email protected]: https://compare-autoinsurance.Org/ SOURCE: Compare-autoinsurance.Org View source version on accesswire.Com:https://www.Accesswire.Com/595055/What-Are-The-Main-Benefits-Of-Comparing-Car-Insurance-Quotes-Online View photos
to request, modification Contact us at Here or [email protected]
 |
 |
 |
